Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function

American Journal of Physiology

Volumn 277, Issue 1 PART 1, 1999, Pages

  Stevens, Troy ^a   Creighton, Judy ^a   Thompson, W Joseph ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Adenyl cyclase; Calcium; Phosphodiesterase; Pulmonary edema; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL TYPE; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INHIBITION; LUNG ENDOTHELIUM; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD-AIR BARRIER; CALCIUM; CELLS, CULTURED; CYCLIC AMP; ENDOTHELIUM; ISOPROTERENOL; LUNG; MALE; PHENOTYPE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032768780     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.1.l119     Document Type: Article

References (48)

1. Adamson, R. H., B. Liu, G. N. Fry, L. L. Rubin, and F. E. Curry. Microvascular permeability and number of tight junctions are modulated by cAMP. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H1885-H1894, 1998.
2. Adkins, W., J. Barnard, S. May, A. Seibert, J. Haynes, and A. Taylor. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J. Appl. Physiol. 74: 492-497, 1992.
3. Ashikaga, T., S. J. Strada, and W. J. Thompson. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells. Biochem. Pharmacol. 54: 1071-1079, 1997.
4. Barnard, J. W., A. F. Seibert, V. R. Prasad, D. A. Smart, S. J. Strada, A. E. Taylor, and W. J. Thompson. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. J. Appl. Physiol. 77: 774-781, 1994.
5. Bernard, G. R., J. M. Luce, C. L. Sprung, J. E. Rinaldo, R. M. Tate, W. J. Sibbald, K. Kariman, S. Higgins, R. Bradley, C. A. Metz, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med. 317: 1565-1570, 1987.
6. Brigham, K., R. Bowers, and J. Haynes. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ. Res. 45: 292-297, 1979.
7. 2+ entry. Am. J. Physiol. 276 (Lung Cell. Mol. Physiol. 20): L41-L50, 1999.
8. 2+-inhibitable adenylyl cyclase and pulmonary microvascular permeability. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L22-L30, 1997.
9. 2+-sensitive adenylyl cyclases. Adv. Second Messenger Phosphoprotein Res. 32: 23-51, 1998.
10. Cooper, D. M., N. Mons, and J. W. Karpen. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374: 421-424, 1995.
11. Del Vecchio, P., A. Siflinger-Birnboim, P. N. Belloni, L. A. Holleran, H. Lum, and A. B. Malik. Culture and characterization of pulmonary microvascular endothelial cells. In Vitro Cell. Dev. Biol. 28A: 711-715, 1992.
12. Diwan, A., R. Honkanen, R. C. Schaeffer, Jr., S. Strada, and W. Thompson. Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells. J. Cell. Physiol. 171: 259-270, 1997.
13. Engels, P., K. Fichtel, and H. Lubbert. Expression and regulation of human and rat phosphodiesterase type IV isogenes. FEBS Lett. 350: 291-295, 1994.
14. Garcia, J. G., and K. L. Schaphorst. Regulation of endothelial cell gap formation and paracellular permeability. J. Investig. Med. 43: 117-126, 1995.
15. Garcia, J. G., K. L. Schaphorst, S. Shi, A. D. Verin, C. M. Hart, K. S. Callahan, and C. E. Patterson. Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L172-L184, 1997.
16. Haffner, C., T. Jarchau, M. Reinhard, J. Hoppe, S. M. Lohmann, and U. Walter. Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J. 14: 19-27, 1995.
17. Han, J. D., and C. S. Rubin. Regulation of cytoskeleton organization and paxillin dephosphorylation by cAMP. Studies on murine Y1 adrenal cells. J. Biol. Chem. 271: 29211-29215, 1996.
18. Horvath, C., T. Ferro, G. Jesmok, and A. Malik. Recombinant tumor necrosis factor increases pulmonary vascular reactivity independent of neutrophils. Proc. Natl. Acad. Sci. USA 85: 9219-9223, 1988.
19. Kelly, J., T. Stevens, and W. Thompson. Adenylate and guanylate cyclase assays. In: Current Protocols in Pharmacology, edited by M. Williams and S. Enna. Princeton, NJ: Wiley. In press.
20. 2+ and permeability. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol. 18): L810-L819, 1998.
21. Kishi, Y., T. Ashikaga, and F. Numano. Phosphodiesterases in vascular endothelial cells. Adv. Second Messenger Phosphoprotein Res. 25: 201-213, 1992.
22. Lugnier, C., and V. B. Schini. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem. Pharmacol. 39: 75-84, 1990.
23. Lum, H., and A. Malik. Regulation of vascular endothelial barrier function. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L223-L241, 1994.
24. Moore, T., P. Khimenko, and A. Taylor. Mechanisms of Ischemia-Reperfusion Injury in the Lung. New York: Futura, 1998.
25. Moore, T., and A. Taylor. Pathophysiology. Oxford, UK: Oxford University Press, 1998.
26. Moore, T. M., G. H. Brough, P. Babal, J. J. Kelly, M. Li, and T. Stevens. Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L574-L582, 1998.
27. Moore, T. M., P. M. Chetham, J. J. Kelly, and T. Stevens. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L203-L222, 1998.
28. 20-dependent tension development. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol. 18): L1024-L1029, 1998.
29. Nelson, H. S. New developments in bronchodilator therapy. Curr. Opin. Pulm. Med. 2: 35-39, 1996.
30. Novembre, E., A. Cianferoni, R. Bernardini, L. Mugnaini, C. Caffarelli, G. Cavagni, A. Giovane, and A. Vierucci. Anaphylaxis in children: clinical and allergologic features. Pediatrics 101: E8, 1998.
31. Reinhard, M., K. Jouvenal, D. Tripier, and U. Walter. Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc. Natl. Acad. Sci. USA 92: 7956-7960, 1995.
32. Richardson, L., and A. Jagoda. Management of life-threatening asthma in the emergency department. Mt. Sinai J. Med. 64: 275-282, 1997.
33. Ryan, U. S., L. A. White, M. Lopez, and J. W. Ryan. Use of microcarriers to isolate and culture pulmonary microvascular endothelium. Tissue Cell 14: 597-606, 1982.
34. Schaeffer, R., Jr., and M. Bitrick, Jr. Effects of human a-thrombin and 8-bromo-cAMP on large and microvessel endothelial monolayer equivalent "pore" radii. Microvasc. Res. 49: 364-371, 1995.
35. Schaphorst, K. L., F. M. Pavalko, C. E. Patterson, and J. G. Garcia. Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. Am. J. Respir. Cell Mol. Biol. 17: 443-455, 1997.
36. Schnitzer, J., A. Siflinger-Birnboim, P. J. DelVecchio, and A. Malik. Segmental differentiation of permeability, protein glycosylation, and morphology of cultured bovine lung vascular endothelium. Biochem. Biophys. Res. Commun. 199: 11-19, 1994.
37. Seibert, A. F., W. J. Thompson, A. Taylor, W. H. Wilborn, J. Barnard, and J. Haynes. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP. J. Appl. Physiol. 72: 389-395, 1992.
38. Souness, J. E., B. K. Diocee, W. Martin, and S. A. Moodie. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Biochem. J. 266: 127-132, 1990.
39. Stevens, T., G. Brough, T. Moore, P. Babal, and W. Thompson. Endothelial Cells. Basel: Birkhauser Verlag, 1998.
40. 2+ and adenylyl cyclase responses in phenotypically distinct pulmonary endothelial cells. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L51-L59, 1997.
41. 2+-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Proc. Natl. Acad. Sci. USA 92: 2696-2700, 1995.
42. Sunahara, R. K., C. W. Dessauer, and A. G. Gilman. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36: 461-480, 1996.
43. Sunahara, R. K., C. W. Dessauer, R. E. Whisnant, C. Kleuss, and A. G. Gilman. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 272: 22265-22271, 1997.
44. Taylor, A., P. Khimenko, T. Moore, and W. Adkins. Fluid Balance. Philadelphia, PA: Lippincott-Raven, 1997.
45. Taylor, D. R., M. R. Sears, and D. W. Cockcroft. The beta-agonist controversy. Med. Clin. North Am. 80: 719-748, 1996.
46. Townsley, M., J. Parker, G. Longenecker, M. Perry, R. Pitt, and A. Taylor. Pulmonary embolism: analysis of endothelial pore sizes in canine lung. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H1075-H1083, 1988.
47. Volcheck, G. W., and J. T. Li. Exercise-induced urticaria and anaphylaxis. Mayo Clin. Proc. 72: 140-147, 1997.
48. Walter, U., J. Geiger, C. Haffner, T. Markert, C. Nehls, R. E. Silber, and P. Schanzenbacher. Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors. Agents Actions Suppl. 45: 255-268, 1995.